Category Archives : Blog


Changing the Clinical Trial Paradigm for Rare and Orphan (R&O) Diseases using Real-World Evidence

Interview with Flora Sandra Siami, MPH. Vice President of Clinical Research, Regulatory Affairs, and Quality Assurance at HealthCore-NERI. Dr. Patti   Read More

Planned knee and hip replacement surgeries are on the rise in the U.S.

January 23, 2019 – At more than $54 billion, spending to treat all orthopedic pain conditions (including pain in the muscles,   Read More

Advancing Real-World Evidence with Pragmatic Clinical Trials: Interview with Dr. Joseph Singer, Chief Medical Officer of HealthCore-NERI

Dr. Patti Peeples, CEO of HealthEconomics.Com, sat down with Dr. Joseph Singer, CMO of HealthCore-NERI, to discuss how pragmatic clinical   Read More

Use of Biosimilar Growth Factor Increases in Supportive Cancer Care

November 26, 2018 MedicalResearch.com Interview with Abiy Agiro, PHD, HealthCore, Inc., Wilmington, Delaware MedicalResearch.com: What is the background for this study? Response:   Read More

Anthem, HealthCore and Novo Nordisk Launch Large, Real-World Pragmatic Study to Understand the Effectiveness of a New Type 2 Diabetes Drug

Real-world study compares Ozempic® (semaglutide) to other standard diabetes therapies WILMINGTON, Del. – October 17, 2018 – (BUSINESS WIRE)–HealthCore, Inc., the   Read More

JAMA-OTO study by researchers at HealthCore and UT Southwestern Medical Center finds surgery, radiation therapy equally effective in treating common type of head and neck cancer

– For both cohorts survival rates at 3 years exceed 75%, an improvement from prior decades DALLAS – Sept. 20,   Read More

Sometimes less is more . . . at least when it comes to radiation therapy for breast cancer

When insurers adopt evidence-based clinical guidelines for the use of radiation therapy in treating consumers with breast cancer, their network   Read More

HealthCore Announces First-Time Direct Access to its Research Data for Improved Insights and Decision Making

WILMINGTON, Del.—May 21, 2018—Life sciences companies can – for the first time – access one of the largest commercially insured   Read More

HealthCore and Blue Cross Blue Shield Association Study Shows Low Uptake of HPV Vaccine Compared to Other Adolescent Immunizations

– Fewer than a third of adolescents received a first dose of HPV vaccine by their 13th birthday – Wide   Read More

Blue Cross Blue Shield Association Study Shows Significant Increase in Children Who Receive All Recommended Vaccines

Proportion of children receiving all CDC recommended vaccines increases 12 percent over seven years – Variations exist in vaccine rates   Read More